About the award

Olink, part of Thermo Fisher Scientific and NovogeneAIT are offering researchers the chance to win a free pilot project using Olink™ Reveal - our NGS platform for accessible, high-throughput proteomics.

Researchers based in Singapore, Australia and New Zealand are invited to apply and explore how Olink Reveal can help you discover deeper biological insights, accelerate your research, and achieve your goals-without impacting your budget.

What You Will Get

High-quality proteomic data
Measure >1000 proteins focusing on actionable, druggable, robustly detected circulating proteins, particularly those involved in inflammation and immune response, using minimal sample volume.
(Learn more https://olink.com/products/olink-reveal)

Expert support
Your project will be run on Olink Reveal with our certified service provider, NovogeneAIT. Novogene will deliver the high-quality Olink proteomics data you can trust.

Don’t miss this opportunity to enhance your research with next-generation protein biomarker profiling.

Program details

Abstract submissions will be accepted until October 28 2026.

Submit an English abstract (maximum 300 words) proposing a pilot research project using the Olink™ Reveal panel. An internal scientific committee will review the submissions and select the winner based on creativity and innovation.

Projects applying Olink™ Reveal to clinical and translational research, including patient stratification, disease mechanism studies, and biomarker discovery, are especially encouraged.

Applicants must be researchers planning to submit a grant application to support a broader research project requiring pilot data, and must satisfy the eligibility requirements set out in the Submission Terms (as defined below). Applicants may not hold current awards directly related to the proposed research.

Two (2) winners will be selected and each will be awarded free analysis of 43 samples on the Olink™ Reveal Panel. Olink’s Certified Service Provider NovogeneAIT Genomics Pte Ltd (Singapore) will process the selected winner’s samples from sample reception to data delivery (generation of proteomics quantification data and basic data analysis).

Winners will be announced on Nov 11, 2026. The winner must ship samples to the designated site before November 30, 2026, after a consultation meeting with an Olink and Novogene specialist. Shipping and handling costs are covered by the winners.

Samples (human plasma, serum, and more) should be delivered to NovogeneAIT in 1.5mL clear tubes. NovogeneAIT will assist with sample randomization, where randomization refers to the random assignment of samples to plates and wells where the experimental variables of interest (e.g. case, control, treatments) are distributed over the plate.

Terms and conditions apply. Read all terms and conditions here.